Beyond Air Inc (XAIR): שווי שוק להכנסות

Beyond Air, Inc. (XAIR) is scaling sales of its respiratory systems through global distributors and hospital networks. The company's P/S ratio reflects the market valuation relative to revenue, which currently stands at 0.50. Equipment rentals and consumables ensure a steady stream of income. The innovative LungFit system replaces bulky gas cylinders with portable lung therapy devices.

Beyond Air, Inc. (XAIR) is moving toward the commercialization of its nitric oxide delivery systems, making revenue the key driver of value. This multiple compares the business's market value to its sales volume, measuring the premium the market is willing to pay per unit of revenue. Analyzing the market capitalization-to-revenue ratio allows for the identification of a stable valuation corridor for the asset. The stability of this range confirms the company's protection against devaluation shocks and the fundamental confidence of investors.